Cartesian Therapeutics Inc (RNAC)
24.50
-1.24
(-4.82%)
USD |
NASDAQ |
May 07, 13:30
Cartesian Therapeutics Revenue (TTM): 26.00M for Dec. 31, 2023
Revenue (TTM) Chart
Historical Revenue (TTM) Data
| Date | Value |
|---|---|
| December 31, 2023 | 26.00M |
| September 30, 2023 | 34.53M |
| June 30, 2023 | 48.69M |
| March 31, 2023 | 82.72M |
| December 31, 2022 | 110.78M |
| September 30, 2022 | 123.92M |
| June 30, 2022 | 127.64M |
| March 31, 2022 | 108.03M |
| December 31, 2021 | 85.08M |
| September 30, 2021 | 67.09M |
| June 30, 2021 | 47.31M |
| March 31, 2021 | |
| December 31, 2020 | |
| September 30, 2020 | |
| June 30, 2020 | |
| March 31, 2020 | |
| December 31, 2019 |
| Date | Value |
|---|---|
| September 30, 2019 | |
| June 30, 2019 | |
| March 31, 2019 | |
| December 31, 2018 | |
| September 30, 2018 | |
| June 30, 2018 | |
| March 31, 2018 | |
| December 31, 2017 | 0.207M |
| September 30, 2017 | 3.12M |
| June 30, 2017 | 4.141M |
| March 31, 2017 | 6.132M |
| December 31, 2016 | 8.083M |
| September 30, 2016 | 7.287M |
| June 30, 2016 | 7.846M |
| March 31, 2016 | 7.065M |
| December 31, 2015 | 6.011M |
Revenues Definition
Revenues measure the total amount of value that a company brings in during a certain period. This is also considered the "top-line" of the income statement. Revenues are used for all operating expenses as well as other line items which eventually lead to the net income for the company. Revenue is an extremely important metric when analyzing a company. A company with efficient margins is able to turn revenues into the most net income.
Revenue (TTM) Range, Past 5 Years
26.00M
Minimum
Dec 2023
127.64M
Maximum
Jun 2022
78.34M
Average
82.72M
Median
Mar 2023